Inventor
LU GENLIANG
US29 patents
⚠️ This page may combine multiple inventors who share the name “LU GENLIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOLECULAR INSIGHT PHARM INC
11 patentsUS8962799B2Feb 24, 2015
Technetium—and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC75 citations97
US8840865B2Sep 23, 2014
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC32 citations97
US10086096B2Oct 2, 2018
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC4 citations83
US9447121B2Sep 20, 2016
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC10 citations83
US9433594B2Sep 6, 2016
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
MOLECULAR INSIGHT PHARM INC5 citations83
US9388144B2Jul 12, 2016
Radiolabeled prostate specific membrane antigen inhibitors
MOLECULAR INSIGHT PHARM INC9 citations83
US10898598B2Jan 26, 2021
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC1 citations72
US10201624B2Feb 12, 2019
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC3 citations72
US9120837B2Sep 1, 2015
Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX
MOLECULAR INSIGHT PHARM INC5 citations72
US11712485B2Aug 1, 2023
Triazine based radiopharmaceuticals and radioimaging agents
MOLECULAR INSIGHT PHARM INC0 citations62
US9422251B2Aug 23, 2016
Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX
MOLECULAR INSIGHT PHARM INC0 citations51
WAVE LIFE SCIENCES LTD
10 patentsUS10450568B2Oct 22, 2019
Oligonucleotide compositions and methods thereof
WAVE LIFE SCIENCES LTD61 citations96
US11013757B2May 25, 2021
Oligonucleotides, compositions and methods thereof
WAVE LIFE SCIENCES LTD19 citations93
US11718638B2Aug 8, 2023
Compounds, compositions and methods for synthesis
WAVE LIFE SCIENCES LTD10 citations84
US11739325B2Aug 29, 2023
Oligonucleotide compositions and methods thereof
WAVE LIFE SCIENCES LTD12 citations83
US11603532B2Mar 14, 2023
Oligonucleotide compositions and methods of use thereof
WAVE LIFE SCIENCES LTD11 citations83
US11597927B2Mar 7, 2023
Oligonucleotide compositions and methods of use thereof
WAVE LIFE SCIENCES LTD11 citations82
US12391942B2Aug 19, 2025
Oligonucleotide compositions and methods of use thereof
WAVE LIFE SCIENCES LTD2 citations70
US12428442B2Sep 30, 2025
Compounds, compositions and methods for synthesis
WAVE LIFE SCIENCES LTD1 citations63
US12403156B2Sep 2, 2025
Oligonucleotides, compositions and methods thereof
WAVE LIFE SCIENCES LTD0 citations62
US12552743B2Feb 17, 2026
Oligonucleotide compositions and methods of use thereof
WAVE LIFE SCIENCES LTD0 citations47
BABICH JOHN W
4 patentsUS8926944B2Jan 6, 2015
Radiolabeled prostate specific membrane antigen inhibitors
BABICH JOHN W60 citations97
US8211401B2Jul 3, 2012
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
BABICH JOHN W93 citations97
US8211402B2Jul 3, 2012
CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer
BABICH JOHN W46 citations93
US8562945B2Oct 22, 2013
Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
BABICH JOHN W31 citations91